test hybrid nested accordion 1° jQuery, 2° Detail/summary

Receiving, unpacking, and placing in storage

All types of hazardous drugs
Engineering Controls
Value
Ventilated engineering control (BSC or CACI)*
No, unless a leak is observed or suspected
Closed system drug transfer device
NA*
Other
NA*
Personal Protective Equipment
Value
Double chemotherapy gloves (ASTM rated)
No (Single pair of gloves)
Protective gown (impervious, single use)
No, unless a leak is observed or suspected
Eye, face, hair, sleeve, and shoe protection
Consider protective sleeves; add additional protection if a leak is observed or suspected
Protective gown (impervious, single use)
No
Respiratory parotection
No, unless a leak is observed or suspected

Pharmacy: Compounding

Formulation: Oral liquid drug
Engineering Controls
Value
Ventilated engineering control (BSC or CACI)*
Yes§
Closed system drug transfer device
NA*
Other
NA*
Personal Protective Equipment
Value
Double chemotherapy gloves (ASTM rated)
Yes
Protective gown (impervious, single use)
Yes
Eye, face, hair, sleeve, and shoe protection
Hair and shoe covers; Add eye and face protection, if not done in a ventilated engineering control
Protective gown (impervious, single use)
Yes
Respiratory parotection
Yes, if not using a ventilated engineering control
Formulation 2
TH1
TH2
TH3
TD11
TD12
TD13
TD21
TD22
TD23
TD31
TD32
TD33
Note. The Table of Control Approaches provides general approaches that should be adapted to facility-specific conditions. For more detailed information on safe handling practices, see the reference list for this table [ASHP 2006; NIOSH 2004a, 2008; ONS 2011, 2018; OSHA 2016; Power and Cyne 2018].
*Abbreviations: BSC: biological safety cabinet; CACI = compounding aseptic containment isolator; CSTD = closed system drug-transfer device; CVE = containment ventilated enclosure; HIPEC = hyperthermic intraperitoneal chemotherapy; NA = not applicable; NG = nasogastric; PAPR = powered air-purifying respirator; PO = per os (by mouth).
Respiratory protection must be selected on the basis of the hazardous drug and its physical form (particulate, vapor, etc.) and other exposure factors. For general activities, a N95 may suffice. Use a surgical N95 respirator if there is potential for splashes of bodily fluids or liquid drugs. When performing activities such as cleaning the BSC or CACI or responding to large spills, a combination particulate/chemical cartridge respirator may be needed.
Compounding is the process of combining, mixing, or altering ingredients by or under the direct supervision of a licensed pharmacist or physician to create a prescribed medication tailored to the needs of an individual patient. See FDA: https://www.fda.gov/drugs/human-drug-compounding/section-503a-federal-food-drug-and-cosmetic-act and https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers.
§For nonsterile preparations, a ventilated engineering control such as a fume hood, Class I BSC or CVE is sufficient if the ventilated engineering control exhaust is either (1) HEPA filtered and appropriately exhausted to the outside of the building (preferred) or (2) filtered with redundant HEPA filters in series and recirculated back into the C-SCA. Although these activities are recommended in ventilated engineering controls, they may not be possible under some treatment scenarios (e.g., time-sensitive activities in the emergency department). If the activity is performed in a ventilated engineering control that is used for sterile intravenous preparations, a thorough cleaning and disinfecting is required following the activity.
Sterile gloves are required for aseptic drug preparation in a BSC or CACI.
**Needed if the patient might resist (infant, unruly patient, patient predisposed to spitting, patient with difficulty swallowing, or veterinary patient) or if the formulation is hard to swallow.
††Intravenous tubing already attached and primed.
‡‡Activities such as cleaning floors may not require eye or respiratory protection but cleaning a BSC or CACI may require it.

Pharmacy Contact Info:

Main Inpatient Pharmacy: ext 4599, 3503
Fax: 704-878-7283

Director of Pharmacy - Randi Raynor, PharmD: ext 4501
Clinical Coordinator - Laura Rollings, PharmD: ext 4597
Pharmacy Informaticist - Stephen Pringle, PharmD: ext 7645
Pharmacy Technician Supervisor - Amy Wingler, CPhT: ext 7385
Pharmacy Automation Coordinator (Omnicell) - Melissa Fulford, CPhT: ext 3556



This site is intended for the staff of Iredell Health System. While others may view accessible pages, Iredell Health System makes no warranty, express or implied, as to the use of this information outside of Iredell Health System. The content of this policy and procedure document serves as guidance to the delivery of quality patient care. Care providers are expected to exercise critical thinking and situational awareness skills, and in specific situations to take such action as is necessary for the delivery of quality patient care.